An HLA class I peptide-binding assay based on competition for binding to class I molecules on intact human B cells
Sjoerd H. van der Burg(Leiden University Medical Center), W. Martin Kast(University of Southern California), Andreas J. A. Bremers(Radboud University Nijmegen), Jan W. Drijfhout(Leiden University), Willemien E. Benckhuijsen(Leiden University), Elisabeth Ras(Leiden University), C J Melief(Leiden University)
Cited by 90
Related Papers
Therapeutic cancer vaccines
|Journal of Clinical Investigation|2015|1.1k
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
|Nature Medicine|1995|1.1k
The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.
|The Journal of Immunology|1994|851
Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells
|European Journal of Immunology|1993|840